Screener
LivaNova LIVN Neuromodulation — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: LivaNova’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001639691-26-000090
FAQ
- What is LivaNova's neuromodulation — goodwill?
- LivaNova (LIVN) reported neuromodulation — goodwill of $398.75M in Q2 2026.
- How has LivaNova's neuromodulation — goodwill changed year-over-year?
- LivaNova's neuromodulation — goodwill decreased by 0.0% year-over-year, from $398.75M to $398.75M.
- What is the long-term trend for LivaNova's neuromodulation — goodwill?
- Over 4 years (2021 to 2025), LivaNova's neuromodulation — goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $1.6B to $1.6B.
- What does neuromodulation — goodwill mean?
- Represents the intangible asset created when the purchase price of an acquired business within the Neuromodulation segment exceeds the fair value of its identifiable net assets. It reflects the premium paid for expected synergies and market position.
Ask your AI about LivaNova's neuromodulation — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude